314 related articles for article (PubMed ID: 31545117)
1. Usefulness of combination with both continuous administration of hypoxic cytotoxin and mild temperature hyperthermia in boron neutron capture therapy in terms of local tumor response and lung metastatic potential.
Masunaga SI; Sakurai Y; Tanaka H; Takata T; Suzuki M; Sanada Y; Tano K; Maruhashi A; Ono K
Int J Radiat Biol; 2019 Dec; 95(12):1708-1717. PubMed ID: 31545117
[No Abstract] [Full Text] [Related]
2. Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.
Masunaga S; Sakurai Y; Tanaka H; Suzuki M; Liu Y; Kondo N; Maruhashi A; Kinashi Y; Ono K
Br J Radiol; 2012 Mar; 85(1011):249-58. PubMed ID: 22391496
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of combined treatment with continuous administration of tirapazamine and mild temperature hyperthermia in γ-ray irradiation in terms of local tumour response and lung metastatic potential.
Masunaga S; Liu Y; Sakurai Y; Tanaka H; Suzuki M; Kondo N; Maruhashi A; Ono K
Int J Hyperthermia; 2012; 28(7):636-44. PubMed ID: 22946564
[TBL] [Abstract][Full Text] [Related]
4. Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis.
Masunaga SI; Sakurai Y; Tano K; Tanaka H; Suzuki M; Kondo N; Narabayashi M; Watanabe T; Nakagawa Y; Maruhashi A; Ono K
Exp Ther Med; 2014 Jul; 8(1):291-301. PubMed ID: 24944637
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
Masunaga SI; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Nagasawa H; Uto Y; Hori H
Jpn J Cancer Res; 2001 Sep; 92(9):996-1007. PubMed ID: 11572769
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
Masunaga S; Nagasawa H; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Int J Hyperthermia; 2006 Jun; 22(4):287-99. PubMed ID: 16754350
[TBL] [Abstract][Full Text] [Related]
7. Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.
Masunaga S; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Suzuki M; Nagata K; Nagasawa H; Uto Y; Hori H
J Cancer Res Clin Oncol; 2003 Jan; 129(1):21-8. PubMed ID: 12618897
[TBL] [Abstract][Full Text] [Related]
8. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
9. Applicability of combination with tirapazamine in boron neutron capture therapy.
Masunaga S; Ono K; Sakurai Y; Hori H; Kobayashi T; Takagaki M; Suzuki M; Kinashi Y; Akaboshi M
Jpn J Cancer Res; 1998 Jul; 89(7):768-74. PubMed ID: 9738984
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
Masunaga S; Ono K; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Nagasawa H; Uto Y; Hori H
Cancer Sci; 2003 Jan; 94(1):125-33. PubMed ID: 12708486
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
Masunaga S; Nagasawa H; Uto Y; Hori H; Suzuki M; Nagata K; Kinashi Y; Ono K
Int J Hyperthermia; 2005 Jun; 21(4):305-18. PubMed ID: 16019857
[TBL] [Abstract][Full Text] [Related]
12. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.
Masunaga S; Ono K; Suzuki M; Takagaki M; Sakurai Y; Kobayashi T; Akuta K; Akaboshi M; Kinashi Y; Abe M
Br J Radiol; 1997 Apr; 70(832):391-8. PubMed ID: 9166076
[TBL] [Abstract][Full Text] [Related]
13. Significance of manipulating intratumor hypoxia in the effect on lung metastases in radiotherapy, with reference to its effect on the sensitivity of intratumor quiescent cells.
Masunaga S; Matsumoto Y; Hirayama R; Kashino G; Tanaka H; Suzuki M; Kinashi Y; Liu Y; Ando K; Ono K
Clin Exp Metastasis; 2009; 26(7):693-700. PubMed ID: 19466568
[TBL] [Abstract][Full Text] [Related]
14. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
Masunaga S; Ono K; Nishimura Y; Kanamori S; Saga T; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):799-807. PubMed ID: 10837967
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
Masunaga S; Nagasawa H; Gotoh K; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Radiat Med; 2006 Feb; 24(2):98-107. PubMed ID: 16715670
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.
Masunaga S; Ono K; Sakurai Y; Takagaki M; Kobayashi T; Kinashi Y; Suzuki M
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):828-39. PubMed ID: 11697329
[TBL] [Abstract][Full Text] [Related]
17. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
18. Significance of manipulating tumour hypoxia and radiation dose rate in terms of local tumour response and lung metastatic potential, referring to the response of quiescent cell populations.
Masunaga S; Matsumoto Y; Kashino G; Hirayama R; Liu Y; Tanaka H; Sakurai Y; Suzuki M; Kinashi Y; Maruhashi A; Ono K
Br J Radiol; 2010 Sep; 83(993):776-84. PubMed ID: 20739345
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of mild temperature hyperthermia combined with continuous tirapazamine administration under reduced dose-rate irradiation with gamma-rays.
Masunaga S; Nagasawa H; Uto Y; Hori H; Nagata K; Suzuki M; Kashino G; Kinashi Y; Ono K
Int J Hyperthermia; 2007 Feb; 23(1):29-35. PubMed ID: 17575721
[TBL] [Abstract][Full Text] [Related]
20. Reoxygenation in quiescent and total intratumor cells following thermal neutron irradiation with or without (10)B-compound-compared with that after gamma-ray irradiation.
Masunaga S; Ono K; Suzuki M; Sakurai Y; Kobayashi T; Takagaki M; Kinashi Y; Akaboshi M
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):391-8. PubMed ID: 10760435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
